Avery Dennison, Preventice partner on wearable sensor technology

PASADENA, CA – Avery Dennison Medical Solutions is partnering with Minneapolis-based Preventice to produce patch­based wearable sensors for clinical monitoring of a patients' unique physiological characteristics.

Preventice develops mobile health applications and patient monitoring systems that deliver continuous care, wherever an individual might be. The apps enable a constant connection and exchange of information between doctors and their patients, officials say, encouraging those patients to stay engaged in managing their health when away from their care providers, while feeding data to clinicians about a patient’s health status without impacting their daily lifestyle.

“Preventice has a unique understanding of clinical care delivery, which when combined with their expertise in mobile device platforms, remote monitoring protocols, algorithms, data management and EMR integration, gives us an advantage in the marketplace,” said Howard Kelly, vice president and general manager, Avery Dennison Medical Solutions.

Through this partnership, Avery Dennison will develop a new version of the Metria patch­based wearable sensor and user interface for the Preventice Care Platform, which creates a real­time, continuous connection between patients and healthcare providers through mobile, cloud­based and sensor technology.

Metria, which incorporates sensor technology from Proteus Biomedical, will be sold as part of the Preventice Care Platform for remote monitoring applications to hospitals and healthcare systems in the United States.

Kelly said the wearable sensors will "offer clinical remote monitoring applications that address the unmet needs of healthcare providers, while helping improve patients’ quality of life and reducing costs."

Avery Dennison Medical Solutions, a business unit of Avery Dennison Corporation, puts its expertise in advanced skin adhesives and material sciences to work developing technologies for medical apps. The company has licensed proprietary algorithms from Preventice for additional clinical applications of the Metria patch­based wearable sensor, which Avery Dennison will continue to manufacture for both partner companies and their respective customers.

“The potential to improve clinical care through the use of on­-body sensors and remote monitoring is endless,” said Jon Otterstatter, co­founder, president and CEO of Preventice. “We’re confident that the addition of Avery Dennison Medical Solutions to our ecosystem of partners who are focused on healthcare innovation creates a new level of sophistication in monitoring technology. It also supports Preventice’s laser ­focus on providing physicians with new monitoring solutions to significantly improve the patient experience and clinical outcomes.”